Filing Details

Accession Number:
0001325812-12-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-23 17:00:52
Reporting Period:
2012-02-21
Filing Date:
2012-02-23
Accepted Time:
2012-02-23 17:00:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492749 Laurence Reid 300 Third Street
Cambridge MA 02142
Svp, Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-21 930 $10.75 11,681 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,052 Indirect by Managed Account
Footnotes
  1. The purchase reported on this Form 4 was made by the reporting person in connection with the Company's Public Offering of Common Stock.
  2. The reporting person owns 1,052 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.